News

Syensqo Completes Comprehensive Share Purchase Program

Syensqo Completes Comprehensive Share Purchase Program

Syensqo Successfully Completes Its Share Purchase Program

Syensqo is excited to announce the successful conclusion of its recent share purchase program, marking a significant milestone in the company’s growth strategy. By executing this initiative, Syensqo has showcased its ongoing commitment to enhancing shareholder value and aligning its operational practices with the long-term interests of its investors.

Overview of the Share Purchase Program

The share purchase program, which was authorized by Syensqo's Board of Directors, aimed to fulfill both current and anticipated obligations related to its Long Term Incentive Plans for employees. Launched earlier this year, the program resulted in the acquisition of 983,000 shares, accounting for approximately 0.93% of the company's outstanding shares. Total investments reached EUR 74.35 million, with shares bought at an average price of EUR 75.64 each, demonstrating Syensqo's financial strength and strategic foresight.

Recent Transactions and Buyback Details

In accordance with the applicable legal obligations, Syensqo has provided detailed information regarding its share purchases. During the period from October 21 to October 23, 2024, the company purchased a total of 48,468 shares across various marketplaces.

Share Purchase Summary

The share buybacks within this short timeframe included multiple transactions across different platforms. Notably, on October 21, 2024, several shares were acquired at varying prices, contributing to the total repurchase count. These buybacks reaffirm Syensqo's proactive approach in managing its capital and enhancing shareholder equity.

Share Ownership as of October 23, 2024

As of October 23, 2024, Syensqo holds a total of 1,634,372 shares, distributed as follows: 983,000 shares from the completed share purchase program and an additional 651,372 shares controlled through Syensqo Stock Option Management SRL. This clear structure of shareholding reflects the company’s commitment to transparency and effective management of its resources.

About Syensqo

Syensqo is a dynamic science company dedicated to crafting innovative solutions that positively impact the everyday lives of individuals and communities worldwide. With a highly skilled workforce exceeding 13,000 associates, the company thrives on fostering collaboration among diverse experts to drive advancements in science and technology.

Contributing to Sustainability

The products developed by Syensqo play a crucial role in promoting safer and more sustainable solutions across several sectors, including home goods, transportation, and healthcare. By embracing a circular economy ethos, Syensqo endeavors to pioneer technologies that not only serve current needs but also pave the way for a sustainable future.

Contact Information

For inquiries or further information, please reach out to our Investor Relations team:

Sherief Bakr: +44 7920 575 989
Bisser Alexandrov: +33 607 635 28

Loïc Flament: +32 478 69 74 20
Callie Gauzer: +1 908 642 7363

Perrine Marchal: +32 478 32 62 72
Laetitia Schreiber: +32 487 74 38 07

Frequently Asked Questions

What was the total amount invested in the share purchase program?

Syensqo invested a total of EUR 74.35 million in the share purchase program.

How many shares were repurchased during the program?

A total of 983,000 shares were repurchased, representing about 0.93% of the company’s outstanding shares.

What is the average purchase price per share?

The average purchase price for the shares bought was EUR 75.64.

When was the share purchase program launched?

The program was launched on June 25, 2024.

Who should I contact for more information about Syensqo?

You can contact the Investor Relations team directly for any inquiries or additional information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HSBC Boosts Tender Offer: Capital Management Maneuver

Updated Category News Views 56

HSBC Raises Stake in Its Own Game See folks, when HSBC announces it's bumping up the ceiling on buying back its own securities, you know there's a game afoot in the capital management arena. They raised the offering to snag up these $3 billion 6% perpetuals from $1 billion up to a hefty $1.5 billion. It's like they’re saying, 'Hey, let’s tighten the belt and make sure...

Continue Reading
SAS: A Leader in AML Transaction Monitoring Tech

Updated Category News Views 90

The Evolving Landscape of AML Solutions Banks are drowning in a sea of alerts these days, making it tough to sift through and identify real threats. In this wild scenario, SAS has snagged the spotlight, with Chartis Research tipping its hat to them again. Their Anti-Money Laundering (AML) technology is planted right at the cutting edge of this rapidly changing landscape....

Continue Reading
Aries Ignites a Social Renaissance in La Jolla

Updated Category News Views 83

The Dawn of Aries: A Beacon for Social Change Coming out of nowhere, Aries is set to make waves in La Jolla, and no, I'm not talking about another swell hitting the shores. Instead, we're witnessing a new chapter for the rooftop of Hotel La Jolla, where an investment of over a cool million bucks aims to deliver a slice of European flare right here on the Pacific. A...

Continue Reading
iQIYI's AI Resurrects 90-Year-Old Lost Film

Updated Category News Views 24

A Nod to the Past with Tech of Tomorrow Diving into the nitty-gritty of iQIYI's latest cinematic triumph, there's a world where film meets futuristic AI, turning a motley crew of photos and clippings into a full-fledged movie. It's sorcery, if you ask me. "Visiting Shanghai after Sixty Years", vanished for nearly 90 years, has been crafted into existence again by...

Continue Reading
AutoFull Drops C3 Pro—Gaming Chairs With Flair

Updated Category News Views 63

AutoFull Gambles on Flair and Comfort AutoFull is shaking things up with the C3 Pro Series, blending striking aesthetics and tech-focused comfort features aimed right at gamers' sweet spots. Launching ahead of the Black Friday buzz, these new models promise to add some serious pizzazz to your gaming setup, whether it's the Advanced model's extra features or the more basic...

Continue Reading
Major Donations Boost Mesothelioma Research Funding

Updated Category News Views 104

Significant Boosts in Mesothelioma Support November's chill didn't slow down major support for mesothelioma initiatives. On October 22, 2026, during the grand setting of the Foundation's 2026 International Symposium on Malignant Mesothelioma in The Woodlands, Texas, MesoCare.org and Danziger & De Llano, LLP stepped up big time. Their philanthropic moves weren't just about...

Continue Reading
Kuaishou Prepares for Q3 Financial Reveals—November 19

Updated Category News Views 53

We're watching the countdown to November 19, 2026, when Kuaishou Technology plans to spill the beans on its third-quarter earnings. Now, the clock's ticking not just in Beijing but across the financial landscape, as investors everywhere hold their breaths, hoping for some juicy financial insights from this colossal social platform. It's a heavyweight showdown any stock...

Continue Reading
AiNET Prevails in Breach of Contract Jury Verdict

Updated Category News Views 44

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Continue Reading
Custom Antibody Market Eyes $1.13B by 2031 Growth

Updated Category News Views 152

Examining the Custom Antibody Market's Growth Projections The custom antibody market's been reeling in some serious attention lately. With the muscle to hit $1.13 billion by the end of 2031, this market's not slouching around. We're talking about a 9.5% compound annual growth rate here, folks. Now that's a figure that gives you something to chew over your coffee. What...

Continue Reading
Alley Cat Allies Sues Lincolnton Over Cat Shooting

Updated Category News Views 9

Legal Battle Over a Cat's Tragic End Picture the scene: a peaceful neighborhood in Lincolnton, Georgia, where the serenity was ripped apart by the shocking shooting of Piper the cat. This isn't some playground scuffle, my friends. Alley Cat Allies has taken this tragedy to the courts, filing a lawsuit against the city and its mayor. What's at stake here isn't just legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Research Frontiers Reports Significant Revenue Growth in Q1

Updated Category News Views 246

Research Frontiers Reports Strong Financial Results for Q1 WOODBURY, N.Y. — Research Frontiers Inc. (NASDAQ: REFR) has released its financial results for the first quarter of 2025, demonstrating robust growth in revenue. The management team will engage with stakeholders during a conference call set for later today to discuss these outcomes and share insights on recent...

Continue Reading
Gentoo Media Shares Boosted by Recent Acquisition News

Updated Category News Views 103

Gentoo Media's Share Acquisition Update Today, news emerged about a significant share acquisition involving Gentoo Media Inc., a prominent player in the online gambling and sports betting industry. MJ Foundation Fundacja Rodzinna, associated with Mateusz Juroszek, a board member of Gentoo Media, has successfully acquired 27,000 shares at an average price of SEK 20.98 per...

Continue Reading
XTIA Experiences Major Stock Collapse, Hits Unprecedented Low

Updated Category News Views 925

XTIA Stock Experiences Significant Downturn In recent market developments, XTIA stock has fallen to an alarming price of $0.08, marking a troubling 52-week low. This dramatic drop is a clear indication of the challenges the company has faced over the past year, with a staggering decline of around -99.01%. Investors are increasingly worried as the stock struggles to...

Continue Reading
Samsung and Apple's Rivalry: The Foldable Phone Showdown

Updated Category News Views 238

Samsung's Bold Move in the Foldable Market Samsung Electronics Co., Ltd (OTC: SSNLF) has made a significant impact in the smartphone industry with the release of its latest innovation. The Galaxy Z TriFold, a revolutionary device designed to fold twice and transform into a 10-inch display, is a game changer in the realm of foldable phones. This new model showcases...

Continue Reading
Investigation into MoonLake Immunotherapeutics Sparks Concern

Updated Category News Views 305

Investigation Into MoonLake Immunotherapeutics MoonLake Immunotherapeutics, a clinical stage biotechnology company, is making headlines due to an investigation initiated by a leading securities law firm. Investors are understandably worried after the company's stock price plummeted significantly following disappointing results from a critical drug trial. The VELA Trials...

Continue Reading